309 related articles for article (PubMed ID: 12472579)
1. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?
Léticée N; Kaplan C; Lémery D
Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952
[TBL] [Abstract][Full Text] [Related]
5. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
Grimaldi CM; Chen F; Scudder LE; Coller BS; French DL
Blood; 1996 Sep; 88(5):1666-75. PubMed ID: 8781422
[TBL] [Abstract][Full Text] [Related]
6. Immunization against platelet glycoprotein IIb-IIIa in Glanzmann's thrombasthenia.
Taaning E; Knudsen FU; Thorsen S; Jønsson V
Eur J Haematol; 1997 May; 58(5):360-1. PubMed ID: 9222293
[No Abstract] [Full Text] [Related]
7. Glanzmann's thrombasthenia: updated.
Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
[TBL] [Abstract][Full Text] [Related]
8. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
[TBL] [Abstract][Full Text] [Related]
9. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
[TBL] [Abstract][Full Text] [Related]
10. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
[TBL] [Abstract][Full Text] [Related]
11. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
12. Acquired Glanzmann's thrombasthenia associated with acute lymphoblastic leukemia.
André JM; Galambrun C; Trzeciak MC; Dargaud Y; Kaplan-Gouet C; Jallu V; Bertrand Y
J Pediatr Hematol Oncol; 2005 Oct; 27(10):554-7. PubMed ID: 16217260
[TBL] [Abstract][Full Text] [Related]
13. Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases.
Porcelijn L; Huiskes E; Maatman R; de Kreuk A; de Haas M
Vox Sang; 2008 Nov; 95(4):324-30. PubMed ID: 19138263
[TBL] [Abstract][Full Text] [Related]
14. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE
Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137
[TBL] [Abstract][Full Text] [Related]
15. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
[TBL] [Abstract][Full Text] [Related]
16. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia.
Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M
Nephron; 1994; 68(4):442-8. PubMed ID: 7870229
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of Glanzmann's thrombasthenia.
Badhe BA; Jayanthi S; Datta T
Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies.
Kashyap R; Kriplani A; Saxena R; Takkar D; Choudhry VP
J Obstet Gynaecol Res; 1997 Jun; 23(3):247-50. PubMed ID: 9255036
[TBL] [Abstract][Full Text] [Related]
19. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
Di Minno G; Coppola A; Di Minno MN; Poon MC
Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
[TBL] [Abstract][Full Text] [Related]
20. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
